| Application no. and date | 17804979.7 (espacenet) (Federated) (European Patent Register), 20171018 | | Patent/reg. no. and date | DK/EP 3528817, 20220525 | | Publication date | 20190828 | | Priority no. and date | US 201662409833 P, 20161018, US 201762516594 P, 20170607 | | EP pub. no. and date |
EP 3528817 20190828 | | Effective date | | | Applicant/owner | Madrigal Pharmaceuticals, Inc., 200 Barr Harbor Drive, Suite 400
West Conshohocken, Pennsylvania 19428, US | | Applicant ref. no. | 1627380 | | Inventor | TAUB, Rebecca, 1218 Valley Road
Villanova
PA 19085, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/53 (2006.01) , A61P 1/16 (2006.01) , A61P 3/06 (2006.01) , A61P 43/00 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF LEVERFORSTYRRELSER ELLER LIPIDFORSTYRRELSER MED EN THR-BETA-AGONIST | | Int. application no. | US2017057203 | | Int. publication no. | WO2018075650 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
